Tirzepatide Gallery
$$MultiPurposeText$$
See examples of our Tirzepatide work and results.
What Our Clients Say
$$MultiPurposeText$$
Read testimonials from our satisfied customers
Excellent service! The salon is always clean, professional, and welcoming. Nicole recreate...more
Great salon! I have loved every treatment!
(Translated by Google) It wasn't so good because I don't speak English, but my nails look ...more
Melissa gave me the best round brush blowout I’ve ever had
I have been coming here for over 6 months now for various beauty needs - nails, wax, blowo...more
Booked a couples massage that comes with a 50 minute massage and 50 minute jacuzzi. Highly...more
Frequently Asked Questions
Get answers to common questions about Tirzepatide.
Tirzepatide activates both GIP and GLP-1 receptors, reducing appetite, improving insulin sensitivity, and slowing gastric emptying. Combined with lifestyle changes and medical supervision, this dual mechanism promotes significant weight reduction and better metabolic markers over weeks to months.
Ideal candidates are adults with overweight or obesity who haven’t achieved goals through diet and exercise alone and who have no contraindications. A clinical consultation, medical history review, and baseline labs at Catalia determine suitability and individualized dosing.
Clients typically see progressive weight loss, reduced appetite, and improved blood glucose and lipid profiles. Results vary by individual, adherence, and dose escalation, often showing measurable changes within several weeks and more substantial outcomes over months.
Many patients notice appetite suppression and early weight changes within two to four weeks, with clearer metabolic improvements after several weeks. Optimal benefits accumulate over months with dose adjustments, nutrition counseling, and ongoing medical monitoring.
Common side effects include nausea, mild gastrointestinal upset, and temporary digestive changes that often diminish with dose titration. Serious reactions are rare. We monitor side effects closely and adjust treatment or discontinue if safety concerns arise.
Tirzepatide is given as a once-weekly subcutaneous injection with a gradual dosing schedule to minimize side effects. Catalia clinicians provide training on administration, schedule follow-ups, and coordinate labs to monitor safety and effectiveness.